463 related articles for article (PubMed ID: 35397496)
1. Anti-cancer peptide-based therapeutic strategies in solid tumors.
Karami Fath M; Babakhaniyan K; Zokaei M; Yaghoubian A; Akbari S; Khorsandi M; Soofi A; Nabi-Afjadi M; Zalpoor H; Jalalifar F; Azargoonjahromi A; Payandeh Z; Alagheband Bahrami A
Cell Mol Biol Lett; 2022 Apr; 27(1):33. PubMed ID: 35397496
[TBL] [Abstract][Full Text] [Related]
2. Peptide-based targeted therapeutics: Focus on cancer treatment.
Araste F; Abnous K; Hashemi M; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2018 Dec; 292():141-162. PubMed ID: 30408554
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
4. The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides as Drug Delivery Systems Based on Tumor Microenvironment.
Zhang Q; Liu N; Wang J; Liu Y; Wang K; Zhang J; Pan X
Mol Pharm; 2023 Feb; 20(2):789-809. PubMed ID: 36598861
[TBL] [Abstract][Full Text] [Related]
5. Peptide cargo administration: current state and applications.
Rohira H; Arora A; Kaur P; Chugh A
Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
[TBL] [Abstract][Full Text] [Related]
6. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.
Wanjale MV; Kumar GSV
Expert Opin Drug Deliv; 2017 Jun; 14(6):811-824. PubMed ID: 27690671
[TBL] [Abstract][Full Text] [Related]
7. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
[TBL] [Abstract][Full Text] [Related]
11. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
[TBL] [Abstract][Full Text] [Related]
13. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
Gao H; Zhang Q; Yang Y; Jiang X; He Q
Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
16. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter.
Higa M; Katagiri C; Shimizu-Okabe C; Tsumuraya T; Sunagawa M; Nakamura M; Ishiuchi S; Takayama C; Kondo E; Matsushita M
Biochem Biophys Res Commun; 2015 Feb; 457(2):206-12. PubMed ID: 25562654
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
Zorko M; Jones S; Langel Ü
Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
[TBL] [Abstract][Full Text] [Related]
19. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
20. Tumor-homing peptide and its utility for advanced cancer medicine.
Kondo E; Iioka H; Saito K
Cancer Sci; 2021 Jun; 112(6):2118-2125. PubMed ID: 33793015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]